Lasa Supergenics Share Price

NSE: LASA
|
Pharmaceuticals

₹ 5.10

-₹0.22 (-4.14%)
1D
Last updated 12 Oct, 2026, 15:29 IST

Lasa Supergenics Share Price Today

As of 17 Oct 2026, Lasa Supergenics share price is ₹5.10. The stock opened at ₹5.06, compared to its previous close of ₹5.32. During today's trading session, Lasa Supergenics share price moved in the range of ₹5.06 to ₹5.58, with an average price of ₹5.32 for the day. Looking at its last 52-week, the stock has touched a low of ₹5.06 and a high of ₹12.48.

₹5.06
4.14% down today
₹5.58
1D LOW
1D HIGH

Lasa Supergenics Returns Calculator

Volume
1,66,935
Average traded price
₹5.21
Last traded time
03:29:02 12 Oct
Last traded quantity
312
Circuit
L
H
₹4.91
₹5.41
52-week
L
H
₹5.06
₹12.48
Mkt Cap Cr
27.86
P/E
-1.68
P/B
0.56
ROA
-24.96%
ROE
-26.3%
ROCE
-22.21%
Quick Ratio
0.51
EV/EBITDA
-3.86
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Lasa Supergeneri has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Lasa Supergeneri appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,426.9134.865.0511.19%13.74%17.33%2.3121.26
Divis Laboratories2,39,982.2782.0514.3214.6%15.32%19.56%3.554.34
Torrent Pharmaceuticals1,73,447.7481.2620.834.87%25.49%13.85%0.7537.52
Zydus Lifesciences1,13,790.2524.784.28.57%18.59%17.35%0.9114.96
Laurus Labs1,09,143.07100.120.5910.38%16.77%16.14%0.6853.87
Cipla1,07,745.7031.93.117.92%11.27%14.95%2.518.2
Dr. Reddy's Laboratories1,01,338.5332.012.685.48%11.07%12.54%1.3516.1
Mankind Pharma97,263.8647.045.977.36%11.74%13.13%0.7425.36
Aurobindo Pharma96,375.8025.972.546.34%9.25%11.76%1.1512.24
Lupin89,436.7716.143.9914.47%23.76%24.88%1.429.55

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Lasa Supergenics

ISIN
INE670X01014
Sector Market Cap
₹ 27.86 Cr

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and others. It specializes in catalyst chemistry and manufactures anthelmintic/ veterinary API products with production capabilities and product categories in India. The Company's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The Company's manufacturing facility is located in Chiplun, Maharashtra.

Lasa Supergenics Financial Highlights

  • Revenue: Lasa Supergenics reported revenue of ₹25.34 crore in FY26 vs ₹147.46 crore in FY25. It showed a decrease of 82.82% on a yearly basis.
  • Operating Profit: Lasa Supergenics reported an operating loss of ₹34.61 crore in FY26 vs ₹19.38 crore in FY25. It showed a decrease of 78.59% on a year-on-year basis.
  • Net Profit: Lasa Supergenics reported a net loss of ₹34.09 crore in FY26 vs ₹14.76 crore in FY25. It showed a decrease of 130.96% on a yearly basis.

Lasa Supergenics Quarterly Result Highlights

  • Lasa Supergenics reported revenue of ₹1.33 crore in Jun 2026, compared with ₹0.09 crore in Mar 2026, representing an increase of 1,577.78% on a quarter-on-quarter (QoQ) basis.
  • Lasa Supergenics reported an operating loss of ₹3.47 crore in Jun 2026, compared with ₹3.98 crore in Mar 2026, representing an increase of 12.81% on a quarter-on-quarter (QoQ) basis.
  • Lasa Supergenics reported a loss of ₹3.58 crore in Jun 2026, compared with ₹4.16 crore in Mar 2026, reflecting an increase of 13.94% on a QoQ basis.
  • The earnings per share (EPS) of Lasa Supergenics stood at ₹6.80 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
53.65%
FII
0.00%
Other DII
0.00%
Retail and other
46.35%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jun 20250.00%
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--
Day
Open / Close
Change %
12 Oct 26
₹5.06 / ₹5.16
-3.01%
05 Oct 26
₹5.32 / ₹5.32
-5.00%
28 Sep 26
₹5.60 / ₹5.60
-4.92%
21 Sep 26
₹5.89 / ₹5.89
-5.00%
Show more

Lasa Supergenics Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹25.14₹142.45₹104.34₹129.57
Other Income₹0.20₹5.01₹0.10₹1.80
Total Revenue₹25.34₹147.46₹104.43₹131.37
Total Expenses₹38.91₹151.17₹114.77₹153.74
Profit Before Tax-₹34.61-₹19.38-₹19.11-₹42.27
Tax-₹0.52-₹4.63₹2.62-₹3.64
Profit After Tax-₹34.09-₹14.76-₹21.73-₹38.62
EPS - Basic-₹6.80-₹2.95-₹4.34-₹7.71
EPS - Diluted-₹6.80-₹2.95-₹4.34-₹7.71

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹34.61-₹19.38-₹19.11-₹22.37
Income before WC changes-₹8.67₹9.10-₹10.69-₹26.44
Change in Assets₹11.40-₹3.81₹6.82₹12.24
Change in Liabilities-₹10.42-₹8.17₹6.01-₹3.06
Change in WC₹0.97-₹11.98₹12.83₹9.18
Cash flow from Operations-₹7.69-₹2.88₹2.14-₹17.30
Cash flow from Investing₹0.34₹8.21-₹0.40₹11.19
Cash flow from Financing₹7.37-₹5.66-₹1.93-₹4.16
Total Cash Flow₹0.01-₹0.33-₹0.19-₹10.27
Cash (Start of the year)₹0.28₹0.61₹0.80₹11.07
Cash (End of the year)₹0.29₹0.28₹0.61₹0.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹55.83₹69.02₹112.98₹124.63
Current Assets₹10.44₹32.51₹37.89₹39.22
Total Assets₹66.27₹101.53₹150.87₹163.85
Current Liabilities₹16.77₹17.15₹48.87₹42.73
Net Current Asset-₹6.34₹15.36-₹10.98-₹3.51
Non-Current Liabilities-₹0.12₹0.66₹5.32₹2.84
Equity Capital₹49.62₹83.71₹96.68₹118.29
Total Equity & Liabilities₹66.27₹101.53₹150.87₹163.85
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
14.64
Bearish
ATR (14)
0.33
Neutral
STOCH(9,6)
5.15
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
56.87
Bearish
UO(9)
16.18
Bullish
ROC(12)
-25.43
Bearish
WillR(14)
-95.76
Bullish
Period
Simple value
Exponential vaue
5D
5.63
5.6
10D
6.16
5.99
20D
6.57
6.4
50D
7
6.88
100D
7.38
7.24
Volume trend — traded volume by day
12 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Lasa Supergenics
Pharmaceuticals
Add Stock
Add Another

Lasa Supergenics Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.